Peter A Friedman

Title: The Innovations of Peter A. Friedman

Introduction

Peter A. Friedman is an accomplished inventor based in Lebanon, NH (US). He has made significant contributions to the field of biotechnology, particularly in the development of antisense oligonucleotides. His work has the potential to impact various medical applications, showcasing his innovative spirit and dedication to advancing science.

Latest Patents

Peter A. Friedman holds a patent for a "Voltage-gated calcium channel and antisense oligonucleotides thereto." This patent describes an antisense oligonucleotide of 10 to 35 nucleotides in length that can hybridize with a region of the .alpha..sub.1 subunit of the SA-Cat channel gene DNA or mRNA. The patent also includes pharmaceutical compositions containing this antisense oligonucleotide and methods for utilizing it. This innovation highlights his expertise in molecular biology and its applications in medicine.

Career Highlights

Peter A. Friedman is currently associated with Barnes-Jewish Hospital, where he continues to work on groundbreaking research. His role at the hospital allows him to collaborate with other professionals in the field and contribute to advancements in healthcare. His dedication to research and innovation has established him as a notable figure in his area of expertise.

Collaborations

Peter has worked alongside esteemed colleagues such as Elizabeth L. Barry and Keith A. Hruska. These collaborations have fostered an environment of shared knowledge and innovation, further enhancing the impact of their collective work.

Conclusion

Peter A. Friedman exemplifies the spirit of innovation through his patent and contributions to biotechnology. His work not only advances scientific understanding but also holds promise for future medical applications. His career reflects a commitment to improving health outcomes through research and collaboration.